These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3884056)

  • 1. Bromocriptine-related psychosis and treatment.
    Shukla S; Turner WJ; Newman G
    Biol Psychiatry; 1985 Mar; 20(3):326-8. PubMed ID: 3884056
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid enlargement of non-functioning pituitary tumour following withdrawal of bromocriptine.
    Clark JD; Wheatley T; Edwards OM
    J Neurol Neurosurg Psychiatry; 1985 Mar; 48(3):287. PubMed ID: 3981206
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychotic reactions during treatment of pituitary tumours with dopamine agonists.
    Turner TH; Cookson JC; Wass JA; Drury PL; Price PA; Besser GM
    Br Med J (Clin Res Ed); 1984 Oct; 289(6452):1101-3. PubMed ID: 6435792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute psychosis secondary to bromocriptine treatment in a patient with a prolactinoma.
    Cabeza GA; Flores LF; Iñiguez IE; Calarco ZE; Valencia PF
    Rev Invest Clin; 1984; 36(2):147-9. PubMed ID: 6484333
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bromocriptine therapy of prolactinoma and hyperprolactinemia].
    Wu JZ
    Zhonghua Nei Ke Za Zhi; 1983 Oct; 22(10):611-4. PubMed ID: 6673930
    [No Abstract]   [Full Text] [Related]  

  • 6. Postpartum psychosis induced by bromocriptine.
    Canterbury RJ; Haskins B; Kahn N; Saathoff G; Yazel JJ
    South Med J; 1987 Nov; 80(11):1463-4. PubMed ID: 3686155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment complexities in psychosis associated with cabergoline treatment in patients having pituitary prolactinomas.
    Gupta P; Tundup T; Singh J; Deb KS; Verma R; Kumar N
    Asian J Psychiatr; 2018 Jan; 31():129-132. PubMed ID: 29482124
    [No Abstract]   [Full Text] [Related]  

  • 8. Long term suppression of prolactin concentrations after bromocriptine induced regression of pituitary prolactinomas.
    Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):117-8. PubMed ID: 3917709
    [No Abstract]   [Full Text] [Related]  

  • 9. gamma-Hydroxybutyrate withdrawal and chloral hydrate.
    Hutto B; Fairchild A; Bright R
    Am J Psychiatry; 2000 Oct; 157(10):1706. PubMed ID: 11007738
    [No Abstract]   [Full Text] [Related]  

  • 10. Improvement of ejaculatory incompetence with bromocriptine in a man with prolactin-secreting pituitary tumor.
    Oseko F; Taniguchi A; Kono T; Imura H; Komatsu Y
    J Urol; 1983 Apr; 129(4):835-6. PubMed ID: 6842715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.
    Sadoul JL; Thyss A; Freychet P
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):179-83. PubMed ID: 1543025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone withdrawal psychosis.
    Levinson I; Galynker II; Rosenthal RN
    J Clin Psychiatry; 1995 Feb; 56(2):73-6. PubMed ID: 7852256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemic response after bromocriptine withdrawal in women with prolactin-secreting pituitary tumors.
    Maxson WS; Dudzinski M; Handwerger SH; Hammond CB
    Fertil Steril; 1984 Feb; 41(2):218-23. PubMed ID: 6698215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent prolactinoma and meningioma following irradiation and bromocriptine treatment.
    Kolodny J; Dluhy RG
    Am J Med; 1985 Jan; 78(1):153-5. PubMed ID: 3966480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid-induced psychosis treated with risperidone.
    DeSilva CC; Nurse MC; Vokey K
    Can J Psychiatry; 2002 May; 47(4):388-9. PubMed ID: 12025444
    [No Abstract]   [Full Text] [Related]  

  • 16. Bromocriptine treatment of prolactin-secreting tumors: surgical implications.
    Weiss MH; Wycoff RR; Yadley R; Gott P; Feldon S
    Neurosurgery; 1983 Jun; 12(6):640-2. PubMed ID: 6877546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persisting suppression of prolactin secretion after long-term treatment with bromocriptine in patients with prolactinomas.
    Eversmann T; Fahlbusch R; Rjosk HK; von Werder K
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):413-27. PubMed ID: 574700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine induced psychosis in acromegaly.
    Br Med J (Clin Res Ed); 1983 Jan; 286(6358):50-1. PubMed ID: 6401459
    [No Abstract]   [Full Text] [Related]  

  • 19. Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression.
    Hancock KW; Scott JS; Lamb JT; Gibson RM; Chapman C
    Br J Obstet Gynaecol; 1980 Jun; 87(6):523-9. PubMed ID: 7397087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin-producing pituitary tumors: medical therapy.
    Vaughn TC; Hammond CB
    Clin Obstet Gynecol; 1980 Jun; 23(2):403-11. PubMed ID: 6994967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.